A citation-based method for searching scientific literature

Eric Trépo, Stefano Romeo, Jessica Zucman-Rossi, Pierre Nahon. J Hepatol 2016
Times Cited: 151







List of co-cited articles
987 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease.
Stefano Romeo, Julia Kozlitina, Chao Xing, Alexander Pertsemlidis, David Cox, Len A Pennacchio, Eric Boerwinkle, Jonathan C Cohen, Helen H Hobbs. Nat Genet 2008
53

Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease.
Julia Kozlitina, Eriks Smagris, Stefan Stender, Børge G Nordestgaard, Heather H Zhou, Anne Tybjærg-Hansen, Thomas F Vogt, Helen H Hobbs, Jonathan C Cohen. Nat Genet 2014
702
32

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.
Zobair M Younossi, Aaron B Koenig, Dinan Abdelatif, Yousef Fazel, Linda Henry, Mark Wymer. Hepatology 2016
25

Genetics and epigenetics of NAFLD and NASH: Clinical impact.
Mohammed Eslam, Luca Valenti, Stefano Romeo. J Hepatol 2018
435
21


Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.
Zobair Younossi, Quentin M Anstee, Milena Marietti, Timothy Hardy, Linda Henry, Mohammed Eslam, Jacob George, Elisabetta Bugianesi. Nat Rev Gastroenterol Hepatol 2018
19


Design and validation of a histological scoring system for nonalcoholic fatty liver disease.
David E Kleiner, Elizabeth M Brunt, Mark Van Natta, Cynthia Behling, Melissa J Contos, Oscar W Cummings, Linda D Ferrell, Yao-Chang Liu, Michael S Torbenson, Aynur Unalp-Arida,[...]. Hepatology 2005
18

A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease.
Noura S Abul-Husn, Xiping Cheng, Alexander H Li, Yurong Xin, Claudia Schurmann, Panayiotis Stevis, Yashu Liu, Julia Kozlitina, Stefan Stender, G Craig Wood,[...]. N Engl J Med 2018
374
18

Accumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis.
Soumik BasuRay, Yang Wang, Eriks Smagris, Jonathan C Cohen, Helen H Hobbs. Proc Natl Acad Sci U S A 2019
126
17


The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.
Naga Chalasani, Zobair Younossi, Joel E Lavine, Michael Charlton, Kenneth Cusi, Mary Rinella, Stephen A Harrison, Elizabeth M Brunt, Arun J Sanyal. Hepatology 2018
16

A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis.
Shaoqing He, Christopher McPhaul, John Zhong Li, Rita Garuti, Lisa Kinch, Nick V Grishin, Jonathan C Cohen, Helen H Hobbs. J Biol Chem 2010
445
15

Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis.
Eriks Smagris, Soumik BasuRay, John Li, Yongcheng Huang, Ka-man V Lai, Jesper Gromada, Jonathan C Cohen, Helen H Hobbs. Hepatology 2015
228
15

PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells.
Carlo Pirazzi, Luca Valenti, Benedetta Maria Motta, Piero Pingitore, Kristina Hedfalk, Rosellina Margherita Mancina, Maria Antonella Burza, Cesare Indiveri, Yvelise Ferro, Tiziana Montalcini,[...]. Hum Mol Genet 2014
231
15


Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice.
Daniel Lindén, Andrea Ahnmark, Piero Pingitore, Ester Ciociola, Ingela Ahlstedt, Anne-Christine Andréasson, Kavitha Sasidharan, Katja Madeyski-Bengtson, Magdalena Zurek, Rosellina M Mancina,[...]. Mol Metab 2019
102
15

The PNPLA3 I148M variant modulates the fibrogenic phenotype of human hepatic stellate cells.
Francesca Virginia Bruschi, Thierry Claudel, Matteo Tardelli, Alessandra Caligiuri, Thomas M Stulnig, Fabio Marra, Michael Trauner. Hepatology 2017
134
14

Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma.
Y-L Liu, G L Patman, J B S Leathart, A-C Piguet, A D Burt, J-F Dufour, C P Day, A K Daly, H L Reeves, Q M Anstee. J Hepatol 2014
318
14

A feed-forward loop amplifies nutritional regulation of PNPLA3.
Yongcheng Huang, Shaoqing He, John Zhong Li, Young-Kyo Seo, Timothy F Osborne, Jonathan C Cohen, Helen H Hobbs. Proc Natl Acad Sci U S A 2010
256
14

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.
Mohammed Eslam, Philip N Newsome, Shiv K Sarin, Quentin M Anstee, Giovanni Targher, Manuel Romero-Gomez, Shira Zelber-Sagi, Vincent Wai-Sun Wong, Jean-François Dufour, Jörn M Schattenberg,[...]. J Hepatol 2020
14

A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis.
Stephan Buch, Felix Stickel, Eric Trépo, Michael Way, Alexander Herrmann, Hans Dieter Nischalke, Mario Brosch, Jonas Rosendahl, Thomas Berg, Monika Ridinger,[...]. Nat Genet 2015
296
13

The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent.
Rosellina Margherita Mancina, Paola Dongiovanni, Salvatore Petta, Piero Pingitore, Marica Meroni, Raffaela Rametta, Jan Borén, Tiziana Montalcini, Arturo Pujia, Olov Wiklund,[...]. Gastroenterology 2016
365
13

TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease.
Yang-Lin Liu, Helen L Reeves, Alastair D Burt, Dina Tiniakos, Stuart McPherson, Julian B S Leathart, Michael E D Allison, Graeme J Alexander, Anne-Christine Piguet, Rodolphe Anty,[...]. Nat Commun 2014
370
13

MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.
Mohammed Eslam, Arun J Sanyal, Jacob George. Gastroenterology 2020
13

Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits.
Elizabeth K Speliotes, Laura M Yerges-Armstrong, Jun Wu, Ruben Hernaez, Lauren J Kim, Cameron D Palmer, Vilmundur Gudnason, Gudny Eiriksdottir, Melissa E Garcia, Lenore J Launer,[...]. PLoS Genet 2011
654
12

17-Beta Hydroxysteroid Dehydrogenase 13 Is a Hepatic Retinol Dehydrogenase Associated With Histological Features of Nonalcoholic Fatty Liver Disease.
Yanling Ma, Olga V Belyaeva, Philip M Brown, Koji Fujita, Katherine Valles, Suman Karki, Ynto S de Boer, Christopher Koh, Yanhua Chen, Xiaomeng Du,[...]. Hepatology 2019
137
12

Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro.
Carlo Pirazzi, Martin Adiels, Maria Antonella Burza, Rosellina Margherita Mancina, Malin Levin, Marcus Ståhlman, Marja-Riitta Taskinen, Marju Orho-Melander, Jeanna Perman, Arturo Pujia,[...]. J Hepatol 2012
195
11


Human PNPLA3-I148M variant increases hepatic retention of polyunsaturated fatty acids.
Panu K Luukkonen, Auli Nick, Maarit Hölttä-Vuori, Christoph Thiele, Elina Isokuortti, Susanna Lallukka-Brück, You Zhou, Antti Hakkarainen, Nina Lundbom, Markku Peltonen,[...]. JCI Insight 2019
61
18

Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase.
Manju Kumari, Gabriele Schoiswohl, Chandramohan Chitraju, Margret Paar, Irina Cornaciu, Ashraf Y Rangrez, Nuttaporn Wongsiriroj, Harald M Nagy, Pavlina T Ivanova, Sarah A Scott,[...]. Cell Metab 2012
202
10

PNPLA3, CGI-58, and Inhibition of Hepatic Triglyceride Hydrolysis in Mice.
Yang Wang, Nora Kory, Soumik BasuRay, Jonathan C Cohen, Helen H Hobbs. Hepatology 2019
88
11

Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis.
John Zhong Li, Yongcheng Huang, Ruchan Karaman, Pavlina T Ivanova, H Alex Brown, Thomas Roddy, Jose Castro-Perez, Jonathan C Cohen, Helen H Hobbs. J Clin Invest 2012
184
9

Recombinant PNPLA3 protein shows triglyceride hydrolase activity and its I148M mutation results in loss of function.
Piero Pingitore, Carlo Pirazzi, Rosellina M Mancina, Benedetta M Motta, Cesare Indiveri, Arturo Pujia, Tiziana Montalcini, Kristina Hedfalk, Stefano Romeo. Biochim Biophys Acta 2014
119
9

MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals.
Benedetta Donati, Paola Dongiovanni, Stefano Romeo, Marica Meroni, Misti McCain, Luca Miele, Salvatore Petta, Silvia Maier, Chiara Rosso, Laura De Luca,[...]. Sci Rep 2017
131
9

TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content.
Hovsep Mahdessian, Apostolos Taxiarchis, Sergej Popov, Angela Silveira, Anders Franco-Cereceda, Anders Hamsten, Per Eriksson, Ferdinand van't Hooft. Proc Natl Acad Sci U S A 2014
204
9

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection.
Richard K Sterling, Eduardo Lissen, Nathan Clumeck, Ricard Sola, Mendes Cassia Correa, Julio Montaner, Mark S Sulkowski, Francesca J Torriani, Doug T Dieterich, David L Thomas,[...]. Hepatology 2006
9

Human fatty liver disease: old questions and new insights.
Jonathan C Cohen, Jay D Horton, Helen H Hobbs. Science 2011
9

NAFLD: a multisystem disease.
Christopher D Byrne, Giovanni Targher. J Hepatol 2015
9

Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci.
Stefan Stender, Julia Kozlitina, Børge G Nordestgaard, Anne Tybjærg-Hansen, Helen H Hobbs, Jonathan C Cohen. Nat Genet 2017
196
9

Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease.
Luca Valenti, Ahmad Al-Serri, Ann K Daly, Enrico Galmozzi, Raffaela Rametta, Paola Dongiovanni, Valerio Nobili, Enrico Mozzi, Giancarlo Roviaro, Ester Vanni,[...]. Hepatology 2010
466
9



PNPLA3 I148M Variant Influences Circulating Retinol in Adults with Nonalcoholic Fatty Liver Disease or Obesity.
Alison Mondul, Rosellina M Mancina, Andrea Merlo, Paola Dongiovanni, Raffaela Rametta, Tiziana Montalcini, Luca Valenti, Demetrius Albanes, Stefano Romeo. J Nutr 2015
70
11

New trends on obesity and NAFLD in Asia.
Jian-Gao Fan, Seung-Up Kim, Vincent Wai-Sun Wong. J Hepatol 2017
539
8


Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease.
Paola Dongiovanni, Salvatore Petta, Cristina Maglio, Anna Ludovica Fracanzani, Rosaria Pipitone, Enrico Mozzi, Benedetta Maria Motta, Dorota Kaminska, Raffaela Rametta, Stefania Grimaudo,[...]. Hepatology 2015
325
8

Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis.
Giovanni Targher, Christopher D Byrne, Amedeo Lonardo, Giacomo Zoppini, Corrado Barbui. J Hepatol 2016
681
8

PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseases.
Jie Yang, Eric Trépo, Pierre Nahon, Qian Cao, Christophe Moreno, Eric Letouzé, Sandrine Imbeaud, Thierry Gustot, Jacques Deviere, Stéphanie Debette,[...]. Int J Cancer 2019
50
16

Splice variant rs72613567 prevents worst histologic outcomes in patients with nonalcoholic fatty liver disease.
Carlos J Pirola, Martin Garaycoechea, Diego Flichman, Marco Arrese, Julio San Martino, Carla Gazzi, Gustavo O Castaño, Silvia Sookoian. J Lipid Res 2019
78
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.